Theses›Listed companies›ABT

Abbott Laboratories

NASDAQ: ABT · US

Markets it anchors
015254060+cheapfairfullexpensive18.5x 015254060+cheapfairfullexpensive18.5x
Fig. 1The screen as it last ran, 6 Nov 2026: Full at 18.5x forward earnings; the table below has the latest prices. A screen flags where to look; it is not a valuation.
Market datarefreshed 6 Nov 2026
Price109.93 USD
Market value$190B
Revenue, last 12 months$48B
Forward P/E18.5x
EV to revenue4.7x
Gross and operating margin57% · 12%

Not advice. Where I hold a position it is disclosed to members, with the reasoning.